baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Call 230 PGR 21.03.../ DE000MG100J8 /

25/06/2024 21:28:08	Chg.-0.10	Bid22:00:34	Ask22:00:34	Underlying	Strike price	Expiration date	Option type
1.35EUR	-6.90%	- Bid Size: -	- Ask Size: -	Progressive Corporat...	230.00 USD	21/03/2025	Call

GlobeNewswire 22:30 argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...

GlobeNewswire 21:30 Intellia Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with ...

GlobeNewswire 16:30 CORRECTION: Capricor Therapeutics

GlobeNewswire 14:30 Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire 14:00 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial

GlobeNewswire 13:30 Zevra Therapeutics Expands Executive Leadership Team

GlobeNewswire 13:30 Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical D...

GlobeNewswire 13:00 Breckenridge Distillery Releases Award-Winning Collectors Art Series Collaboration With Abby Wren

GlobeNewswire 12:15 Fujifilm Launches 128-Slice Computed Tomography System, FCT iStream, with Vision Modeling Iterative ...

GlobeNewswire 12:05 Lulus Expands Footwear Offering By Welcoming Vans Into All-New “Lulus Loves” Capsule

GlobeNewswire 24/06 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...

GlobeNewswire 24/06 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...

GlobeNewswire 24/06 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...

GlobeNewswire 19/06 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens

GlobeNewswire 18/06 Afamelanotide in fair-skinned Parkinson’s patients

GlobeNewswire 14/06 Progressive Reports May 2024 Results

GlobeNewswire 13/06 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...

GlobeNewswire 12/06 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...

GlobeNewswire 12/06 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...

GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...

GlobeNewswire 11/06 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...

GlobeNewswire 11/06 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...

GlobeNewswire 10/06 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...

GlobeNewswire 10/06 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...

TeleTrader 09/06 EP updated results, EPP with 189 seats

Morgan Stanley Call 230 PGR 21.03.../ DE000MG100J8 /

If you wish to receive reply to your feedback, please provide your email address.